Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

Rita Montalcini, Italian Biologist, Dies at 103

Rita Levi Montalcini, an Italian biologist who defied World War II fascist anti-Semitism and went on to win a Nobel Prize in medicine, died at the age of 103.

Her niece told reporters that Levi Montalcini died quietly in her sleep on Sunday at her home in Rome.

Tributes poured in from across the Italian spectrum for one of Italy’s most admired and honored women. The Rome newspaper Il Messaggero said news of her death was greeted on the Internet “with the same affection and same outpouring of messages as would have accompanied the death of a rock star or cinema idol.”

Recognized as a moral as well as intellectual authority, Montalcini was named a Senator for Life, one of Italy’s highest honors, in 2001.

“A luminous figure in the history of science has passed away,” President Giorgio Napolitano said in a statement. Napolitano praised Levi-Montalcini’s scientific work as well as her commitment to fostering the rights of women.

Rome Mayor Gianni Alemanno called her death a great loss “for all of humanity.” In a statement, Alemanno said Levi Montalcini had represented “civic conscience, culture and the spirit of research of our time.”

Levi Montalcini, who never married, was born to a Jewish family in Turin in 1909. During World War II, because of anti-Semitic restrictions by the fascist government, she worked secretly in a clandestine laboratory that she built in her bedroom.

She and her family fled Turin in 1941, first to a mountain village and in 1943 to Florence, where they spent the rest of the war in hiding. After the war, Levi Montalcini moved to the United States and eventually divided her time between the U.S. and Italy.

In 1986 she shared the Nobel Prize in medicine with American biochemist Stanley Cohen for groundbreaking research carried out in the U.S. unlocking the mysteries of the cell.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version